Yi, S., Zhou, K., Liu, N., Sang, W., Huang, R., Wang, Y., Zhang, C., Wu, F., Li, Y., Sun, M., Mi, J., Ding, K., Gao, S., Zhang, Q., Hua, H., Chu, X., Cheng, J., Abudureyimu, A., Zhou, L., Chow, C., Chen, T., Liang, Z., Vezan, R., Qiu, L. (2025). Primary analysis of a multicenter, open-label, phase 2 study of sonrotoclax (BGB-11417) monotherapy in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL). Blood. https://doi.org/10.1182/blood-2025-5666